An Efficacy Study in Gastric and Gastroesophageal Junction Cancer Comparing Ipilimumab Versus Standard of Care Immediately Following First Line Chemotherapy
Completed · Phase 2
Conditions studied: Locally Advanced (Unresectable) or Metastatic Adenocarcinoma of the Gastric and Gastro-esophageal Junction
In brief
The purpose of the study is to compare the efficacy of Ipilimumab and standard of care as sequential or maintenance treatment immediately after first-line chemotherapy in the treatment of unresectable or metastatic gastric and gastro-esophageal cancer.
Key facts
- Study ID
- NCT01585987
- Run by
- Bristol-Myers Squibb
- People needed
- 143
- Starts
- 2012-07-01
- Expected to finish
- 2015-04-01
- Last updated by the study team
- 2016-05-17
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Mount Sinai Medical Center — Miami Beach, Florida, United States
- Nyu Clinical Cancer Center — New York, New York, United States
- Memorial Sloan Kettering Cancer Center — New York, New York, United States
- The University Of Texas Md Anderson Cancer Center — Houston, Texas, United States
- Local Institution — Montpellier, France
- Local Institution — Nice, France
- Local Institution — Rennes, France
- Local Institution — Toulouse, France
- Local Institution — Mainz, Germany
- Local Institution — Hong Kong, Hong Kong
- Local Institution — Florence, Italy
- Local Institution — Milan, Italy
- Local Institution — Padova, Italy
- Local Institution — Pisa, Italy
- Local Institution — Roma, Italy
- Local Institution — Nagoya, Aichi-ken, Japan
- Local Institution — Saku-shi, Nagano, Japan
- Local Institution — Osaka-sayama-shi, Osaka, Japan
- Local Institution — Kitaadachi-gun, Saitama, Japan
- Local Institution — Katowice, Ochojec, Poland
- Local Institution — Krakow, Poland
- Local Institution — Lodz, Poland
- Local Institution — Olsztyn, Poland
- Local Institution — Moscow, Russia
- Local Institution — Singapore, Singapore
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.